Please use this identifier to cite or link to this item: https://doi.org/10.3390/cancers13092130
Title: Development of a microRNA Panel for Classification of Abnormal Mammograms for Breast Cancer
Authors: Zou, Ruiyang 
Loke, Sau Yeen 
Tan, Veronique Kiak-Mien 
Quek, Swee Tian 
Jagmohan, Pooja 
Tang, Yew Chung
Madhukumar, Preetha 
Tan, Benita Kiat-Tee 
Yong, Wei Sean 
Sim, Yirong 
Lim, Sue Zann 
Png, Eunice
Lee, Shu Yun Sherylyn
Chan, Mun Yew Patrick
Ho, Teng Swan Juliana 
Khoo, Boon Kheng James 
Wong, Su Lin Jill 
Thng, Choon Hua
Chong, Bee Kiang
Teo, Yik Ying 
Too, Heng-Phon 
Hartman, Mikael 
Tan, Ngiap Chuan
Tan, Ern Yu
Lee, Soo Chin 
Zhou, Lihan
Lee, Ann Siew Gek
Keywords: Science & Technology
Life Sciences & Biomedicine
Oncology
breast cancer
abnormal mammograms
circulating microRNAs
biomarkers
qRT-PCR
CIRCULATING MICRORNAS
SERUM MICRORNA
IDENTIFICATION
BIOMARKER
BLOOD
SIGNATURES
MIRNAS
Issue Date: 1-May-2021
Publisher: MDPI
Citation: Zou, Ruiyang, Loke, Sau Yeen, Tan, Veronique Kiak-Mien, Quek, Swee Tian, Jagmohan, Pooja, Tang, Yew Chung, Madhukumar, Preetha, Tan, Benita Kiat-Tee, Yong, Wei Sean, Sim, Yirong, Lim, Sue Zann, Png, Eunice, Lee, Shu Yun Sherylyn, Chan, Mun Yew Patrick, Ho, Teng Swan Juliana, Khoo, Boon Kheng James, Wong, Su Lin Jill, Thng, Choon Hua, Chong, Bee Kiang, Teo, Yik Ying, Too, Heng-Phon, Hartman, Mikael, Tan, Ngiap Chuan, Tan, Ern Yu, Lee, Soo Chin, Zhou, Lihan, Lee, Ann Siew Gek (2021-05-01). Development of a microRNA Panel for Classification of Abnormal Mammograms for Breast Cancer. CANCERS 13 (9). ScholarBank@NUS Repository. https://doi.org/10.3390/cancers13092130
Abstract: Mammography is extensively used for breast cancer screening but has high false‐positive rates. Here, prospectively collected blood samples were used to identify circulating microRNA (miRNA) biomarkers to discriminate between malignant and benign breast lesions among women with abnormal mammograms. The Discovery cohort comprised 72 patients with breast cancer and 197 patients with benign breast lesions, while the Validation cohort had 73 and 196 cancer and benign cases, respectively. Absolute expression levels of 324 miRNAs were determined using RT-qPCR. miRNA biomarker panels were identified by: (1) determining differential expression between malignant and benign breast lesions, (2) focusing on top differentially expressed miRNAs, and (3) building panels from an unbiased search among all expressed miRNAs. Two‐fold cross‐validation incorporating a feature selection algorithm and logistic regression was performed. A six‐miRNA biomarker panel identified by the third strategy, had an area under the curve (AUC) of 0.785 and 0.774 in the Discovery and Validation cohorts, respectively, and an AUC of 0.881 when differentiating between cases versus those with benign lesions or healthy individuals with normal mammograms. Biomarker panel scores increased with tumor size, stage and number of lymph nodes involved. Our work demonstrates that circulating miRNA signatures can potentially be used with mammography to differentiate between patients with malignant and benign breast lesions.
Source Title: CANCERS
URI: https://scholarbank.nus.edu.sg/handle/10635/208256
ISSN: 20726694
DOI: 10.3390/cancers13092130
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Development of a microRNA Panel for Classification of Abnormal Mammograms for Breast Cancer.pdfPublished version1.29 MBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.